Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124266) titled 'Observation on Dosage Optimization and Safety Advantages of Oliceridine Fumarate Injection for Painless Fiberoptic Bronchoscopy' on May 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Ningbo University
Condition:
Respiratory Diseases
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-11
Target Sample Size: Oliceridine Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319927
Published by HT Digital Content Services with permission from Health Daily Digest...